AI Terminal
Zur Rose Group AG
M&A Activity • Oct 31, 2018
1021_rns_2018-10-31_64ffa86a-e778-4e2c-8399-6ceaafd00072.html
M&A Activity
Open in ViewerOpens in native device viewer
News Details
Corporate | 31 October 2018 07:00
Zur Rose Group AG: Takeover of apo-rot’s mail-order activities successfully completed
EQS Group-News: Zur Rose Group AG / Key word(s): Alliance
31.10.2018 / 07:00
Press release
Zur Rose Group: Takeover of apo-rot’s mail-order activities successfully completed
The Zur Rose Group successfully completed the takeover of apo-rot’s mail-order activities. With this step, the Group continues to consolidate the largest European mail order market Germany and systematically expands its leadership position in Europe.
Investors and analyst contact
Marcel Ziwica, Chief Financial Officer
Email: [email protected], phone: +41 58 810 11 49
Media contact
Lisa Lüthi, Head of Corporate Communications
Email: [email protected], phone: +41 52 724 08 14
Financial Calendar
19 November 2018 Extraordinary General Meeting
23 January 2019 Sales 2018
21 March 2019 Annual results 2018
17 April 2019 Q1/2019 Trading Update
23 May 2019 Annual General Meeting
Zur Rose Group
The Swiss Zur Rose Group is Europe’s largest online pharmacy and one of the leading medical wholesalers in Switzerland. With its business model, it offers high-quality, safe and cost-effective pharmaceutical care and thus contributes to reducing healthcare costs. It is also characterized by the continuous further development of digital services in the field of drug management in order to increase therapy safety. The creation of added value and a pronounced patient orientation make the Group an important strategic partner for service providers, cost units and industry.
The Zur Rose Group is internationally present with strong brands, including Germany’s best-known pharmacy brand DocMorris. The company employs over 1,000 people at various locations and generated a turnover of CHF 983 million in the 2017 financial year. The shares of Zur Rose Group AG are listed on the SIX Swiss Exchange (securities number 4261528, ISIN CH0042615283, ticker ROSE). The CHF 115 million corporate bond issued in July 2018 is also listed on the SIX Swiss Exchange (securities number 42146044, ISIN CH0421460442, ticker ZRO18). Further information at zurrosegroup.com
End of Corporate News
| Language: | English |
| Company: | Zur Rose Group AG |
| Walzmühlestrasse 60 | |
| 8500 Frauenfeld | |
| Switzerland | |
| Phone: | +41 52 724 08 14 |
| Internet: | www.zurrosegroup.com |
| ISIN: | CH0042615283 |
| Listed: | SIX Swiss Exchange |
| End of News | EQS Group News Service |